Clinical practice. Management of an inherited predisposition to breast cancer.

  title={Clinical practice. Management of an inherited predisposition to breast cancer.},
  author={Mark E. Robson and Kenneth Offit},
  journal={The New England journal of medicine},
  volume={357 2},
A healthy 33-year-old woman comes to establish care. She has no breast symptoms, her age at menarche was 14 years, and she has no children. She notes a family history of early-onset breast cancer in her sister, mother, and maternal aunt. Her maternal grandfather died of prostate cancer. What screening and risk-reduction strategies would you advise? 

Figures and Tables from this paper

Management of women who have a genetic predisposition for breast cancer.

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

Article Commentary: Surgical Prophylaxis for Inheritable Malignant Diseases: Colorectal and Gastric Cancer

Investigators have identified several genetic mutations and subsequently developed risk-reduction strategies that sometimes involve surgery, but investigators have no meaningful methods of “preventing” the malignant transformation that occurs as a result of an inherited gene.

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

Germline mutations in the BRCA2 cancer susceptibility gene are associated with an increased risk of pancreatic cancer (PC) and the influence of a family history of PC on BRCa mutation prevalence in patients with breast cancer (BC) is unknown.

Genes, cancer risks, and clinical outcomes.

  • P. Hartge
  • Medicine, Biology
    The New England journal of medicine
  • 2007
Learning whether a patient who has just been given a diagnosis of breast cancer also bears one of the cancer-causing mutations in the BRCA1 or BRCA2 genes may add little to the clinician's ability to

Clinical implications of low-penetrance breast cancer susceptibility alleles

Current understanding of low-penetrance genes is reviewed, with a specific focus on their clinical implications, and the availability of new techniques such as genome-wide association studies ensures that more low-risk alleles will be identified.

Clinical features and management of BRCA1 and BRCA2-associated prostate cancer.

The evidence relating BRCA gene mutations to the risk of PCa, as well as outcomes and response to therapy, are reviewed and an approach to the management of patients with PCa who are carriers of a gene mutation is suggested.

The Cancer Spectrum Related to Hereditary and Familial Breast and Ovarian Cancers

Individuals with a first-degree family member affected with breast cancer have a relative risk of developing breast cancer, which varies with the age at which the affected relative was diagnosed, the number of affected and unaffected family members and, finally, the closeness of the relationship.


A risk management plan should be tailored to each woman, taking into account the level of her short-term (rather than life-time) risk, her lifestyle plans (such as child-bearing), competing risks (particularly in women with a prior cancer) and her personal preferences.



Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

A large number of women with a family history of breast cancer face the task of providing appropriate screening schedules for their patients, and one group for whom this is particularly important are those Women with aFamily history of Breast cancer.

Genetic/familial high-risk assessment: breast and ovarian.

Overview All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair,1,2 but not all of these mutations are inherited from

Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.

The majority of cancers arising in women at increased genetic risk of breast cancer can be detected by planned screening, even in those under age 50, and the trend towards earlier pathological stage in tumours detected during follow-up rounds and the preliminary findings on survival analysis suggest that this approach will prove to be of long-term benefit for breast cancer families.

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction.

Age-specific risks for a woman with one or more relatives affected with breast cancer at various ages at onset are given and genetic models fit previously to these data by the authors have provided evidence for a rare autosomal dominant allele that results in increased susceptibility to breast cancer.

Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.

Although no scientific evidence is available, the Ad Hoc Committee feels that specific management is indispensable and advocates the use of defined and evaluated procedures, and participation in clinical trials.

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.

Addition of MR imaging to the screening regimen for high-risk women may enable detection of otherwise unsuspected breast cancers.

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

MRI appears to be more sensitive than mammography in detecting tumors in women with an inherited susceptibility to breast cancer.

Management of women at increased risk for breast cancer: preliminary results from a new program.

  • P. ChartE. Franssen
  • Medicine
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 1997
These preliminary results suggest that surveillance of women at increased risk for breast cancer may be useful in detecting disease at an early stage and the regular performance of mammography, CBE and BSE appears necessary to achieve these results.

Clinical outcome and service implications of screening women at increased breast cancer risk from a family history.

  • G. GuiG. Kadayaprath R. Eeles
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2006